Tobacco exposure
Full tobacco cessation and second-hand smoke avoidance
Tobacco avoidance is a major health priority even though short-term CRP and IL-6 movement is less predictable than weight, diet, or exercise.
Last reviewed: June 14, 2026
Marker interpretation
Smoking exposure is associated with inflammatory markers, but cessation studies show that CRP may not normalize quickly. Long-term cessation is still ranked because exposure reduction is biologically and clinically important.
Practical focus and cautions
- Prioritize complete cessation over small reductions when daily exposure remains.
- Avoid second-hand smoke where the environment is controllable.
- Use medication, counselling, and structured cessation support when dependence makes quitting difficult.
- Early cessation can coincide with weight change, stress, sleep disruption, or medication use, all of which can affect CRP.
- Do not use a short-term CRP result as proof that quitting tobacco did not matter.
Guideline points
-
TOBACCO 01
Treat all forms of tobacco exposure as harmful; there is no safe level.
-
TOBACCO 02
Avoid second-hand smoke exposure when control over the environment is possible.
-
TOBACCO 03
Use cessation support when nicotine dependence makes quitting difficult.
-
TOBACCO 04
Do not treat reduced cigarette count as equivalent to full cessation when exposure remains daily.
-
TOBACCO 05
Protect adolescents and young adults from nicotine initiation and flavored product marketing.
Sources
- Tobacco World Health Organization - WHO/OMS guidance
- Effect of tobacco smoking cessation on C-reactive protein levels Scientific Reports / PubMed Central - Prospective cohort evidence
- Clinical correlates of change in inflammatory biomarkers: The Framingham Heart Study Atherosclerosis / PubMed - Longitudinal cohort evidence